Health Problems
New US monkeypox vaccine strategy could be huge boost for supply, but much is unknown
Yet the specific efficacy data for the vaccine is not clear, and some experts argue that not enough is known about how the low-dose intradermal strategy might affect the protection it provides in the real world. Even at the original dosage size, “there is no traditional assessment of this vaccine,” Read more…
